Neil W. Gibson
2013
In 2013, Neil W. Gibson earned a total compensation of $1.2M as Chief Scientific Officer at Regulus Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,250 |
|---|---|
| Option Awards | $762,195 |
| Salary | $350,000 |
| Other | $4,832 |
| Total | $1,227,277 |
Gibson received $762.2K in option awards, accounting for 62% of the total pay in 2013.
Gibson also received $110.3K in non-equity incentive plan, $350K in salary and $4.8K in other compensation.
Rankings
In 2013, Neil W. Gibson's compensation ranked 5,750th out of 12,286 executives tracked by ExecPay. In other words, Gibson earned more than 53.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,750 out of 12,286 | 53rd |
Division Manufacturing | 2,001 out of 4,612 | 57th |
Major group Chemicals And Allied Products | 584 out of 1,462 | 60th |
Industry group Drugs | 417 out of 1,156 | 64th |
Industry Pharmaceutical Preparations | 337 out of 890 | 62nd |
Source: SEC filing on April 30, 2015.
Gibson's colleagues
We found one more compensation record of an executive who worked with Neil W. Gibson at Regulus Therapeutics in 2013.
2013
Kleanthis Xanthopoulos
Regulus Therapeutics